Professor of Surgery, UCLA
General Surgery
Dr. Howard A. Reber, MD
|
|
Give Review
Doctor Howard A. Reber, MD practices General Surgery. He went to Perelman School of Medicine at the University of Pennsylvania. He received awards:"America's Top Doctors", "Top Doctors:LA Area", "America's Top Doctors for Cancer", "Top Doctors:Southern California", "Super Doctor" and "Fellow (FACS)". Howard A. Reber is a published physician. He published 88 publications, including: 'Long-term survival in patients with pancreatic ductal adenocarcinoma.' Howard Reber accepts Medicare payments and is registered with Medicare.gov.
Publications
- Long-term survival in patients with pancreatic Ductal adenocarcinoma.
- Surgical Management of Pancreatic Cancer-Pancreaticoduodenectomy.
- Autologous Islet Transplantation With Remote Islet Isolation After Pancreas Resection for Chronic Pancreatitis.
- Current Recommendations for Surveillance and Surgery of IntraDuctal Papillary Mucinous Neoplasms May Overlook Some Patients with Cancer.
- Mucinous cystic neoplasms of the pancreas: are we overestimating malignant potential?
- Locally advanced pancreatic Cancer: association between prolonged preoperative treatment and lymph-node negativity and overall survival.
- Nonfunctional Pancreatic Neuroendocrine Tumors <2 cm on Preoperative Imaging are Associated with a Low Incidence of Nodal Metastasis and an Excellent Overall Survival.
- Pancreatic surgery.
- miR-143 decreases COX-2 mRNA stability and expression in pancreatic Cancer cells.
- Simultaneous knock-down of Bcl-xL and Mcl-1 induces apoptosis through Bax activation in pancreatic Cancer cells.
- Impact of Tumor Grade on Pancreatic Cancer Prognosis: Validation of a Novel TNMG Staging System.
- Perioperative antibiotics for surgical site infection in Pancreaticoduodenectomy: does the SCIP-approved regimen provide adequate coverage?
- Apigenin inhibits NNK-induced focal adhesion kinase activation in pancreatic Cancer cells.
- The evolving management of infected Pancreatic necrosis.
- Evidence for activation of mutated p53 by apigenin in human pancreatic Cancer.
- Neoadjuvant therapy in pancreatic adenoCarcinoma: A meta-analysis of phase II trials.
- Downstaging chemotherapy and alteration in the classic computed tomography/magnetic resonance imaging signs of vascular involvement in patients with pancreaticoBiliary...
- Baicalein, a component of Scutellaria baicalensis, induces apoptosis by Mcl-1 down-regulation in human pancreatic Cancer cells.
- N-myc downstream regulated gene-1 expression correlates with reduced pancreatic Cancer growth and increased apoptosis in vitro and in vivo.
- Cyclooxygenase-2 confers growth advantage to syngeneic pancreatic Cancer cells.
- Overexpression of CXCL5 is associated with poor survival in patients with pancreatic Cancer.
- Operative blood loss and survival in pancreatic Cancer.
- Bioluminescence imaging of angiogenesis in a murine orthotopic pancreatic Cancer model.
- Cystic neoplasms of the pancreas: results of 114 cases.
- A modern review of the operative management of chronic pancreatitis.
- Laparoscopic surgery for Cancer: a systematic review and a way forward.
- Performance of multidetector computed tomographic angiography in determining surgical resectability of pancreatic head adenoCarcinoma.
- Invasive intraDuctal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes.
- Epigenetic regulation affects N-myc downstream-regulated gene 1 expression indirectly in pancreatic Cancer cells.
- Quercetin aglycone is bioavailable in murine pancreas and Pancreatic xenografts.
- Impact of splenectomy on thrombocytopenia, chemotherapy, and survival in patients with unresectable pancreatic Cancer.
- Loss of 15-hydroxyprostaglandin dehydrogenase increases prostaglandin E2 in pancreatic Tumors.
- Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway.
- Pancreatic-pleural fistula is best managed by early operative intervention.
- Pancreatic serous cystadenoCarcinoma: a case report and review of the literature.
- Can neoplastic cystic masses in the head of the pancreas be safely and adequately removed without a whipple resection?
- Utilization of parenteral nutrition following Pancreaticoduodenectomy: is routine jejunostomy tube placement warranted?
- Complete Resection of Ampullary Paragangliomas Confined to the Submucosa on Endoscopic Ultrasound May Be Best Achieved by Radical Surgical Resection.
- Improved survival following pancreaticoduodenectomy to treat adenoCarcinoma of the pancreas: the influence of operative blood loss.
- Distal pancreatectomy: incidence of postoperative diabetes.
- Expression analysis of the prostaglandin E2 proDuction pathway in human pancreatic cancers.
- Mononuclear cell-derived interleukin-1 beta confers chemoresistance in pancreatic Cancer cells by upregulation of cyclooxygenase-2.
- Survival after resection of ampullary Carcinoma: a national population-based study.
- Opposing effects of n-6 and n-3 polyunsaturated fatty acids on pancreatic Cancer growth.
- Natural history of intraDuctal papillary mucinous neoplasms (IPMN): current evidence and implications for management.
- Delayed gastric emptying--what should be required for diagnosis?
- Food, fat, and the inflamed pancreas.
- Delayed progression of Pancreatic intraepithelial neoplasia in a conditional Kras(G12D) mouse model by a selective cyclooxygenase-2 inhibitor.
- Accuracy of staging node-negative pancreas Cancer: a potential quality measure.
- Middle pancreatectomy: why I rarely do it.
- Suramin inhibits not only tumor growth and metastasis but also angiogenesis in experimental pancreatic Cancer.
- Pancreatic regeneration in chronic pancreatitis requires activation of the notch signaling pathway.
- Estrogen receptors in pancreatic Tumors.
- Resection of pancreatic Neuroendocrine tumors: results of 70 cases.
- Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary Cancer: direct quantitative PCR for ALU repeats.
- The clinical significance of MAGEA3 expression in pancreatic Cancer.
- Activation of peroxisome proliferator-activated receptor-gamma decreases pancreatic Cancer cell invasion through modulation of the plasminogen activator system.
- The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic Cancer cell invasion by amplifying mitogen-activated protein kinase...
- The Notch signaling pathway is related to neurovascular progression of pancreatic Cancer.
- Minutes of the Business Meeting of the American Pancreatic Association Thursday, November 4, 2004.
- A xenograft nude mouse model for perineural invasion and recurrence in pancreatic Cancer.
- Management of Pancreatic fistulas after Pancreaticoduodenectomy: results in 437 consecutive patients.
- Prostate stem cell antigen is a putative target for immunotherapy in pancreatic Cancer.
- Local resection of the head of the pancreas with Pancreaticojejunostomy.
- Selective inhibition of endothelin receptor A as an anti-angiogenic and anti-proliferative strategy for human pancreatic Cancer.
- Growth stimulation of COX-2-negative pancreatic Cancer by a selective COX-2 inhibitor.
- VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic Cancer.
- COX and PPAR: possible interactions in pancreatic Cancer.
- Laparoscopic gastrojejunostomy for gastric outlet obstruction in pancreatic Cancer.
- Pancreatic neoplasms.
- Tumor hypoxia correlates with metastatic tumor growth of pancreatic Cancer in an orthotopic murine model.
- Antiangiogenic activity of genistein in pancreatic Carcinoma cells is mediated by the inhibition of hypoxia-inducible factor-1 and the down-regulation of VEGF gene exp...
- Pancreatic Cancer growth is inhibited by blockade of VEGF-RII.
- Improved survival for adenoCarcinoma of the ampulla of Vater: fifty-five consecutive resections.
- Controversies in clinical pancreatology: management of acute idiopathic recurrent pancreatitis.
- Glial cell-derived neurotrophic factor upregulates the expression and activation of matrix metalloproteinase-9 in human pancreatic Cancer.
- PGE(2) is generated by specific COX-2 activity and increases VEGF proDuction in COX-2-expressing human pancreatic cancer cells.
- An orthotopic nude mouse model for evaluating pathophysiology and therapy of pancreatic Cancer.
- Prevention of metastatic pancreatic cancer growth in vivo by inDuction of apoptosis with genistein, a naturally occurring isoflavonoid.
- Evaluation of vascular endothelial growth factor blockade and matrix metalloproteinase inhibition as a combination therapy for experimental human pancreatic Cancer.
- Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic Cancer.
- The selective cyclooxygenase-2 inhibitor nimesulide induces apoptosis in pancreatic Cancer cells independent of COX-2.
- VEGF-RII influences the prognosis of pancreatic Cancer.
- Surgery for acute and chronic pancreatitis.
- Controversies in clinical pancreatology: intraDuctal papillary-mucinous tumor (IPMT): American Pancreatic Association Clinical Symposium.
- Food-derived polyphenols inhibit pancreatic Cancer growth through mitochondrial cytochrome C release and apoptosis.
- Specific targeting of tumor vasculature by diphtheria toxin-vascular endothelial growth factor fusion protein reduces angiogenesis and growth of pancreatic Cancer.
Procedures Preformed
- Cholecystoenterostomy
- Cystectomy
- Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
- Gallbladder Removal (Cholecystectomy), Open
- View All
Conditions Treated
- Abdominal Pain
- Bile Duct Cancer
- Biliary Atresia
- Carcinoma in Situ
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:LA Area
- America's Top Doctors for Cancer
- Top Doctors:Southern California
- Super Doctor
- Fellow (FACS)
Education
-
University of Pennsylvania Health System -
Perelman School of Medicine at the University of Pennsylvania
Hospital
-
Ronald Reagan UCLA Medical Center -
Santa Monica-UCLA Medical Center and Orthopaedic Hospital
Drug Facts
| NPI NUMBER | 1932123049 | |
| NPPES Provider LastName | REBER | |
| NPPES Provider FirstName | HOWARD | |
| NPPES Provider ZIPCode | 900950001 | |
| NPPES Provider State | CA | |
| Specialty Description | General Surgery | |
| Total Claim Count | 18.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1932123049 |
| Last Name Of The Provider | REBER |
| First Name Of The Provider | HOWARD |
| View All |
Similar Doctors
|
|
Dr. Yeong K. Ahn, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yuri S. Genyk, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ji-Lian Cai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip I. Haigh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mohd R. Sheikh, MD |
|
|
Dr. Edward R. Margules, MD |
|
|
Dr. Joseph E. Ahn, MD |
|
|
Dr. Francesco Di Battista, MD |
|
|
Dr. Stewart H. Gleischman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adrian E. Ortega, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Jagajan Karmacharya, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephanie G. Worrell, MD |
|
|
Tae H. Kwak, LAC |